EV/EBITDA:
-11.98-0.08(-0.67%)Summary
- As of today, VKTX EV/EBITDA is -11.98, with a fall of -0.08 (-0.67%) during the most recent trading session on December 22, 2025.
- Over the past year, VKTX EV/EBITDA has increased by +16.35 (+57.71%).
- VKTX EV/EBITDA is now -3522.86% below its all-time high of 0.35.
Performance
VKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VKTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -0.7% | +0.7% | +0.6% |
| 1M1 Month | -4.1% | +4.1% | +3.3% |
| 3M3 Months | -27.2% | +64.3% | +41.8% |
| 6M6 Months | -6.1% | +69.4% | +42.4% |
| YTDYTD | +49.7% | -8.4% | -12.0% |
| 1Y1 Year | +57.7% | -13.2% | -16.4% |
| 5Y5 Years | -128.6% | +1511.6% | +462.8% |
VKTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -11.36 | -5.5% | -13.29 | +9.9% |
| 3M | 3-Month | -8.17 | -46.6% | -14.20 | +15.6% |
| 6M | 6-Month | -8.17 | -46.6% | -18.48 | +35.2% |
| 1Y | 1-Year | -8.10 | -47.9% | -28.63 | +58.2% |
| 3Y | 3-Year | -6.00 | -99.7% | -95.77 | +87.5% |
| 5Y | 5-Year | 0.35 | -3522.9% | -95.77 | +87.5% |
| All-Time | All-Time | 0.35 | -3522.9% | -95.77 | +87.5% |
VKTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.98(+49.7%) |
| 2024 | -23.83(-59.5%) |
| 2023 | -14.94(-80.0%) |
| 2022 | -8.30(-191.2%) |
| Date | Value |
|---|---|
| 2021 | -2.85(+28.2%) |
| 2020 | -3.97(+65.2%) |
| 2018 | -11.42(-893.0%) |
| 2016 | -1.15 |
FAQ
- What is Viking Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
- What is VKTX EV/EBITDA year-to-date change?
- What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Viking Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of VKTX is -11.98
What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high EV/EBITDA is 0.35
What is VKTX EV/EBITDA year-to-date change?
Viking Therapeutics, Inc. EV/EBITDA has changed by +11.85 (+49.73%) since the beginning of the year
What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, VKTX EV/EBITDA has changed by +16.35 (+57.71%)